Navigation Links
Researchers closer to understanding actions of cells involved in atherosclerosis
Date:9/10/2012

TORONTO, Sept. 10, 2012Researchers at St. Michael's Hospital are one step closer to understanding why plaque bursts in coronary arteries and causes heart attacks.

The clue might be something called microRNA-145. MicroRNAs are short chains of bossy molecules that scientists are increasingly coming to realize control a wide variety of biological processes.

Dr. Subodh Verma, a cardiac surgeon at St. Michael's, published a paper in the journal Circulation today, describing for the first time how microRNA-145 gene therapy can drastically reduce the severity and progression of atherosclerosis in mice.

In addition this approach appeared to make the atherosclerotic plaque more stable and less prone to burst.

Atherosclerosis, commonly called hardening of the arteries, is a condition in which fat, cholesterol and other substances build up in the walls of arteries and form hard structures called plaques. It is the leading cause of death in Canada.

Dr. Verma said most heart attacks occur when plaques rupture like a broken eggshell and release their contents into the artery. Researchers are therefore looking for ways to reduce the size of plaques and make them more stable.

One of the key questions is what causes the outer layer of the plaque to finally burst a layer of smooth muscle cells known as the fibrous cap. These cells undergo "phenotypic transformation" in response to various stressful environments and cardiovascular risk factors, making them more likely to rupture and cause heart attacks.

MicroRNA-145 is one of the factors that appear to play a critical role in preventing the transformation of vascular smooth muscle cells into rupture-prone cells.

In atherosclerosis-prone animals, microRNA-145-based gene therapy reduced the plaque size by approximately 50 per cent and increased the collagen content of the plaque and fibrous cap area by 40 to 50 per cent, indicating that this therapy can reduce plaque buildup and also make it less prone to rupture, the inciting event of heart attacks.

The researchers also found that in human atherosclerotic plaques, the amount of microRNA-145 was reduced compared to normal arteries that were free of plaque, providing supporting human insights to the animal study.

"Atherosclerosis continues to be the number one killer in modern societies and finding new ways to treat this problem are needed," said Dr. Verma.

Dr. Fina Lovren, a senior research associate at St Michael's Hospital, carried out the experimental work on this project under the direction of Dr. Verma.


'/>"/>

Contact: Leslie Shepherd
shepherdl@smh.ca
416-864-6094
St. Michael's Hospital
Source:Eurekalert

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Researchers develop a new cell and animal model of inflammatory breast cancer
3. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
4. Researchers Find Gene Mutations That May Be a Key to Autism
5. Researchers find evidence of banned antibiotics in poultry products
6. NJ stroke researchers report advances in spatial neglect research at AAN Conference
7. Autism by the numbers: Yale researchers examine impact of new diagnostic criteria
8. Researchers Map Brain Regions Linked to Intelligence
9. Researchers ID Genes That May Determine Mental Illness
10. Researchers Develop Blood Test for Depression
11. University of Cincinnati researchers win $3.7M grant from US Department of Defense
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... ... The Waismann Method® is providing a faster, safer, and more ... to America’s opioid epidemic. Now, opiate dependent individuals can be treated in a ... shame, stigma, and harmful labeling believed to prevent many of these victims ...
(Date:2/22/2017)... ... ... South Bend’s Lunkerville, the award-winning TV series that catches real people with real ... non-profit organization dedicated to helping military veterans relax, rehabilitate, and reintegrate through kayak fishing. ... Denmark, New Jersey, to fish with war veteran Justin Vail from the New Jersey ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... adults with chronic conditions reported skipping doses or not filling a prescription because ... or under-insured, rates of cost-related problems getting medications were 30-60%*. At ...
(Date:2/22/2017)... ... 22, 2017 , ... Sideline Products participated in the World Horse Expo held ... Seay and his production crew. Tom Seay’s program “Best of America by Horseback” ... Saddle Sidekicks will be featured on April 6, 2017. After the broadcast, the clip ...
(Date:2/22/2017)... ... February 22, 2017 , ... The first-ever National Heart ... advocates, and individuals join together to increase recognition about the risks of heart ... , “Today we mark a nationwide movement to raise awareness about a disease ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) ... quarter and full year 2016 financial results on Thursday, March ... markets. Following the announcement, members of the management team ... results and provide a general corporate update at 4:30 p.m. ... obtained as follows: Thursday, March 2 1:30 ...
(Date:2/22/2017)... 2017  Andre, DiMino, CEO of ADM Tronics Unlimited, ... innovative technologies and products, commented on ADMT,s third quarter ... 2017 in the Company,s quarterly report on Form 10Q ... Andre, DiMino stated "During the quarter ended December 31, ... a larger portion of our engineering efforts into the ...
(Date:2/22/2017)... Clean Holdings, Inc. (Nasdaq: UCTT), a leading developer ... the semiconductor capital equipment, flat panel, medical, energy ... for the fourth quarter and fiscal year ended ... year of extraordinary growth for UCT. Total revenue ... with continued focus on operational excellence resulted in ...
Breaking Medicine Technology: